Trending Topic

bullous pemphigoid
2 mins

Trending Topic

Developed by Touch
Mark CompleteCompleted
BookmarkBookmarked

  The FDA approval of dupilumab represents a major step forward for adults living with bullous pemphigoid (BP), one that is likely to transform how we manage this chronic autoimmune blistering condition. The FDA approval of dupilumab represents a major step forward for adults living with bullous pemphigoid (BP), one that is likely to transform […]

Infectious Diseases

An Introduction to Infectious diseases

Mark CompleteCompleted
BookmarkBookmarked

Dr Niraj Parajuli shares his journey into dermatology, from early motivations to his current work in neglected tropical diseases, rare skin conditions, and digital dermatology. Discover how his global leadership and commitment to health equity are shaping the future of the field.

touchVisionary Voices
Mark CompleteCompleted
BookmarkBookmarked

Physician burnout is at a critical point. In this episode, Nicky speaks with Dr Alfred Atanda about why so many physicians are burning out and what can be done to change the trend. From personal experience to system-wide solutions, Dr Atanda shares valuable insights on improving physician well-being and building a more effective healthcare culture.

Mark CompleteCompleted
BookmarkBookmarked

As 2025 unfolds, the field of dermatology is set for some significant advancements. To get a glimpse of what’s ahead, we turned to our esteemed Expert Faculty members, who shared their expert insights on what they think will be the key innovations shaping this year. From the most exciting trends of 2024 that are gaining momentum to the next breakthroughs poised to redefine patient care, here’s what they had to say.

Developed by Touch
Mark CompleteCompleted
BookmarkBookmarked

Dr. Shari Lipner is a leading expert in dermatology, best known for her specialization in nail disorders. As an Associate Professor of Clinical Dermatology and Director of the Nail Division at New York-Presbyterian/Weill Cornell Medical Center, her work bridges ...

Developed by Touch
Coverage from: Dermatology Congress News 2023

Dr. James Del Rosso (JDR Dermatology Research, Las Vegas, Nevada, USA, and President-Elect American Acne & Rosacea Society) discusses the efficacy and safety results from the CAMP-1 and CAMP-2 studies, highlighting their role in supporting the recent FDA approval cantharidin ...

Developed by Touch
Coverage from: Dermatology Congress News 2023

Molluscum contagiosum, a common skin infection caused by a poxvirus (molluscum contagiosum virus), usually resulting in benign, mild skin disease characterized by lesions appearing anywhere on the body. In this interview, Dr. James Del Rosso (JDR Dermatology Research, Las Vegas, ...

Developed by Touch
Coverage from: Dermatology Congress News 2023

Dermatology and sexual health raise critical topics such as dermatological manifestations linked to STIs e.g. monkeypox and cutaneous syphilis, the effectiveness of vaccination, and the rise in antibiotic resistance to treat cutaneous STIs.  touchDERMATOLOGY were delighted to speak with Dr Georg Stary (Department of Dermatology, Medical University of Vienna, Vienna, Austria) at EADV 2023 to explore present challenges and future directions in addressing these complex and pressing issues. The abstract ‘Vaccination in STIs: What is the current state?’ (Presentation ID PLB-02) and ‘Antibiotic landscape in genital ulcers’ (Presentation ID D2T12.3B) was presented at EADV 2023, Berlin, 11-14 October 2023 #EADVCongress. Questions What dermatological manifestations are associated with STIs? How effective are existing vaccines for STIs, and how have recent developments in vaccinations influenced their development? What do you see as the future directions of STI vaccination? What is the present status of antibiotic resistance in STIs? What challenges do healthcare professionals face in selecting appropriate antibiotics for STIs, given the changing microbial landscape? How could a multifaceted approach impact the prevention of antimicrobial resistant STIs? Disclosures: Georg Stary has nothing to disclose in relation to this video interview. Support: Interview and filming supported by Touch Medical Media Ltd. Interview conducted by Victoria Jones and Katey Gabrysch. Filmed in coverage of the EADV Annual Meeting This content was developed by Touch Medical Media and is not affiliated with the  European Academy of Dermatology & Venereology  (EADV) or the congress. 

Close Popup